Brexit Makes Drug Agency the Most Sought After Regulator in EU
- European Medicines Agency wooed by Sweden, Hungary, Denmark
- Moving EMA would cause ‘tremendous disruption’: Glaxo CEO
This article is for subscribers only.
Forget the bankers: It’s pharmaceutical regulators who many European governments are trying to woo from London following the Brexit vote.
The U.K. capital is home to the European Medicines Agency, which employs almost 900 people and oversees the safety of drugs sold in the European Union, a market of more than 500 million consumers. Once the U.K. splits, the EU may look to relocate it elsewhere within the 28-nation bloc.